Global interest rates are set to remain higher for longer, with Bloomberg Economics forecasting borrowing costs elevated by up to half a pe...

Revenue for Nvidia's biggest server maker ⁠and Apple's ⁠top iPhone assembler jumped to T$2.513 trillion ($78.71 billion) in the April-June ...

Fourth of July weather update: Millions across the eastern United States face dangerous heat this Fourth of July weekend, with temperatures...

Geopolitical tensions easing around the Strait of Hormuz are expected to drive Brent crude prices down to $60 a barrel by year-end, accordi...

Microsoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...

Medical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...

Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...

Japan's Nikkei share average surged on Tuesday, driven by a strong rebound in technology stocks. The benchmark index closed at 70,062.32, m...

India's peak power demand is soaring above 250 GW due to lingering heatwaves, outpacing a sluggish monsoon. Authorities are preparing conti...

Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...